2023
DOI: 10.15698/cst2023.01.275
|View full text |Cite
|
Sign up to set email alerts
|

Poly(ADP-ribose) polymerase-1 and its ambiguous role in cellular life and death

Abstract: The deletion of the gene coding for poly(ADPribose) polymerase-1 (PARP1) or its pharmacological inhibition protects mice against cerebral ischemia and Parkinson’s disease. In sharp contrast, PARP1 inhibitors are in clinical use for the eradication of vulnerable cancer cells. It appears that excessive PARP1 activation is involved in a specific cell death pathway called parthanatos, while inhibition of PARP1 in cancer cells amplifies DNA damage to a lethal level. Hence, PARP1 plays a context-dependent role in ce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 44 publications
0
0
0
Order By: Relevance
“…Nuclear DNA damage may lead to increased energy consumption, and therefore, the mitochondrial alterations may be secondary to faults in nuclear DNA repair and/or DNA damage [8,18]. Alterations in mitochondrial ATP production may be caused by the activation of PARP1, an enzyme that responds to DNA damage [19]. Activated PARP1 utilizes key metabolites which may attenuate pathways for the protection of cells.…”
Section: Parp1 Is Involved In the Pathogenesis Of Progeroid Syndromesmentioning
confidence: 99%
“…Nuclear DNA damage may lead to increased energy consumption, and therefore, the mitochondrial alterations may be secondary to faults in nuclear DNA repair and/or DNA damage [8,18]. Alterations in mitochondrial ATP production may be caused by the activation of PARP1, an enzyme that responds to DNA damage [19]. Activated PARP1 utilizes key metabolites which may attenuate pathways for the protection of cells.…”
Section: Parp1 Is Involved In the Pathogenesis Of Progeroid Syndromesmentioning
confidence: 99%